Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 11Colorectal Neoplasms 10Colonic Neoplasms 4Pancreatic Neoplasms 2Pathologic Complete Response 1Neoplasms 1Neoplasm Metastasis 1Liver Metastasis Colon Cancer 1Carcinoma, Neuroendocrine 1

Interventions

Bevacizumab 2regorafenib 1Radiofrequency Ablation 1PSMA-BCH 1Oxaliplatin 1IFL protocol 1FOLFOXIRI protocol 1Electroporation 1Cetuximab 1CPG-oligonucleotide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liver Metastasis Colon Cancer × FOLFOXIRI protocol × Clear all
NCT04832776 2021-04-06

FOLFOXIRI Plus Cetuximab Versus FOLFOXIRI Plus Bevacizumab in Conversion Therapy of Right-sided Colon Cancer Liver Metastases

Fudan University

Phase 2 Unknown
160 enrolled
Gastrointestinal

Liver Metastasis Colon Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡